Atlas Trials

A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT00977561 · TERMINATED

Trial details

NCT number
NCT00977561
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Carcinoma
Start date
2010-04-01
Primary completion
2011-10-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.